Austria vs Papua New Guinea: Prevalence rate of hypertension in women aged 30-79
Austria
30.2
in 2019
Papua New Guinea
30.1
in 2019
Austria rank
154th
Papua New Guinea rank
156th
Prevalence rate of hypertension in women aged 30-79 over time
- Austria
- Papua New Guinea
How they compare
Austria currently reports 30.2 against 30.1 in Papua New Guinea, a difference of 0.1.
Across all 30 years both countries report, Austria has been ahead every year.
Austria ranks 154th and Papua New Guinea ranks 156th of 195 countries.
Austria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Austria | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 40.42 | 23.39 | 17.03 | Austria |
| 2000s | 38.17 | 22.83 | 15.34 | Austria |
| 2010s | 32.99 | 27.23 | 5.76 | Austria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Austria or Papua New Guinea?
- Austria, at 30.2 against 30.1 in Papua New Guinea as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Austria and Papua New Guinea?
- 0.1, with Austria ahead.
- How many years of comparable data are there for Austria and Papua New Guinea?
- 30 years are reported by both, from 1990 to 2019.
- How do Austria and Papua New Guinea rank globally for prevalence rate of hypertension in women aged 30-79?
- Austria ranks 154th and Papua New Guinea ranks 156th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.